Full Text View
Tabular View
No Study Results Posted
Related Studies
Temozolomide in Treating Patients With Recurrent Malignant Glioma
This study has been completed.
Study NCT00004113   Information provided by National Cancer Institute (NCI)
First Received: December 10, 1999   Last Updated: December 2, 2009   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2001 (Final data collection date for primary outcome measure)
Publications:
Khan RB, Raizer JJ, Malkin MG, Bazylewicz KA, Abrey LE. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas. Neuro-oncol. 2002 Jan;4(1):39-43.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services